PL370080A1 - Methods for preventing and treating bone loss with steroid compounds - Google Patents

Methods for preventing and treating bone loss with steroid compounds

Info

Publication number
PL370080A1
PL370080A1 PL02370080A PL37008002A PL370080A1 PL 370080 A1 PL370080 A1 PL 370080A1 PL 02370080 A PL02370080 A PL 02370080A PL 37008002 A PL37008002 A PL 37008002A PL 370080 A1 PL370080 A1 PL 370080A1
Authority
PL
Poland
Prior art keywords
preventing
methods
bone loss
treating bone
steroid compounds
Prior art date
Application number
PL02370080A
Other languages
English (en)
Polish (pl)
Inventor
Salle Enrico Di
Giorgio Massimini
Colin Lowery
Paul Edward Goss
Original Assignee
Pharmacia Italia Spa
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa, Pharmacia & Upjohn Company filed Critical Pharmacia Italia Spa
Publication of PL370080A1 publication Critical patent/PL370080A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL02370080A 2001-10-10 2002-09-30 Methods for preventing and treating bone loss with steroid compounds PL370080A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32820901P 2001-10-10 2001-10-10

Publications (1)

Publication Number Publication Date
PL370080A1 true PL370080A1 (en) 2005-05-16

Family

ID=23279989

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370080A PL370080A1 (en) 2001-10-10 2002-09-30 Methods for preventing and treating bone loss with steroid compounds

Country Status (12)

Country Link
EP (1) EP1435967A2 (de)
JP (1) JP2005508958A (de)
KR (1) KR20050032507A (de)
CN (1) CN1713915A (de)
BR (1) BR0213162A (de)
CA (1) CA2463142A1 (de)
IL (1) IL161162A0 (de)
MX (1) MXPA04003405A (de)
NZ (1) NZ532064A (de)
PL (1) PL370080A1 (de)
WO (1) WO2003032961A2 (de)
ZA (1) ZA200402734B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053900A1 (en) * 1998-12-23 2004-03-18 Pharmacia Corporation Method of using a COX-2 inhibitor and an aromatase inhibitor as a combination therapy
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
PT103177A (pt) 2003-09-24 2005-03-31 Bioxell Spa 1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos
WO2006114702A2 (en) * 2005-04-25 2006-11-02 Pfizer Products Inc. Pharmaceutical compositions and methods comprising a combination of a selective estrogen receptor modulator and an aromatase inhibitor
PL2580210T3 (pl) 2010-06-10 2017-09-29 Seragon Pharmaceuticals, Inc. Modulatory receptora estrogenowego i ich zastosowania
CA2857057A1 (en) 2011-12-14 2013-06-20 Seragon Pharmaceuticals, Inc. Fluorinated estrogen receptor modulators and uses thereof
RS64535B1 (sr) 2013-09-24 2023-09-29 Fujifilm Corp Farmaceutska kompozicija jedinjenja koje sadrži azot ili njegovu so, ili njihov kompleks sa metalom
BR112018012981A2 (pt) 2015-12-30 2018-12-04 Saint Louis University derivados do ácido meta-azacíclico amino benzoico como antagonistas de pan integrina com melhores propriedades farmacocinéticas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8721384D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia 17-substituted andro-sta-1 4-dien-3-one derivatives
GB2294879A (en) * 1994-10-19 1996-05-15 Merck & Co Inc Cylcooxygenase-2 Inhibitors
US6590079B2 (en) * 1997-01-30 2003-07-08 Ixsys, Incorporated Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same
ID28460A (id) * 1998-07-08 2001-05-24 Lipogenics Inc Komposisi dan metoda untuk perlakuan dan pencegahan penyakit tulang dengan menggunakan tocotrienol
US8278291B1 (en) * 1999-08-13 2012-10-02 Curadis Gmbh Treatment of wrinkles and strias with 4-hydroxyandrostenedione or a derivative thereof

Also Published As

Publication number Publication date
CA2463142A1 (en) 2003-04-24
ZA200402734B (en) 2005-01-13
EP1435967A2 (de) 2004-07-14
MXPA04003405A (es) 2004-06-18
IL161162A0 (en) 2004-08-31
WO2003032961A3 (en) 2003-09-04
JP2005508958A (ja) 2005-04-07
WO2003032961A2 (en) 2003-04-24
BR0213162A (pt) 2004-09-14
NZ532064A (en) 2006-04-28
CN1713915A (zh) 2005-12-28
KR20050032507A (ko) 2005-04-07

Similar Documents

Publication Publication Date Title
IL233205B (en) Substances for the treatment or prevention of pre-eclampsia
EP1411849A4 (de) Gerät und verfahren zur behandlung von gewebe
EP1217963A4 (de) Vorrichtungen und verfahren zur behandlung von gewebe
EP1446114A4 (de) Zusammensetzungen und verfahren zur behandlung von osteoporose
GB0110288D0 (en) Composition and treatment method
EP1200086A4 (de) Methoden zur behandlung oder vorbeugung von schmerzen und angstzuständen
EP1361604A4 (de) Einrichtung und verfahren zur behandlung
AU2002219945A1 (en) Composition and method for treating snoring
EP1446087A4 (de) Verfahren zur behandlung von nichtneuropathischen schmerzen
IL164219A0 (en) Method for treating and preventing hyparathyroidism
HU0200173D0 (en) Method for preventing and treating skin aging
EP1109548A4 (de) Zusammensetzungen und verfahren zur behandlung und vorbeugung von knochenkrankheiten unter verwendung von tocotrienole
EP1351647A4 (de) Zusammensetzungen und verfahren zur behandlung von hyperpigmentation
GB2379761B (en) System and method for appliance adaptation and evolution
AU2002367023A8 (en) Compositions and methods for treating heart failure
IL161073A0 (en) Composition and method for treating diabetes
AU2002365057A8 (en) Compositions and methods for treating heart failure
IL161162A0 (en) Methods for preventing and treating bone loss with steroid compounds
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2006902A (en) Methods and instruments for treating pseudoarthrosis
AU2001218024A1 (en) Methods for treating and preventing alopecia
HK1046853A1 (zh) 治療肝癌的方法及組成物
AU2002352925A8 (en) Method for treating and preventing pancreatitis
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)